New FDA Pulse Oximetry Guidance: Strengths and Weaknesses

The US Food and Drug Administration (FDA) issued new draft regulatory guidance for pulse oximeters related to skin pigment. The guidance is a step forward but it may have unintended consequences. Authors Michael Lipnick, MD, and Philip Bicker, MD, PhD, professors of anesthesia at University of California, San Francisco, discuss this and more with JAMA Executive Editor Gregory Curfman, MD. Related Content: Pulse Oximetry and Skin Pigmentation—New Guidance From the FDA Adherence to FDA Guidance on Pulse Oximetry Testing Among Diverse Individuals, 1996-2024 Addressing Racial and Ethnic Bias in Pulse Oximeters—A Wicked Problem Evaluating the Accuracy of Pulse Oximetry in Children According to Race

You can listen to New FDA Pulse Oximetry Guidance: Strengths and Weaknesses online on Radio and Podcast. Open the player on this page to stream the available audio.

New FDA Pulse Oximetry Guidance: Strengths and Weaknesses is an episode from JAMA Author Interviews: Covering research in medicine, science, & clinical practice. For physicians, researchers, & clinicians. by American Medical Association.

This episode is 16:50 long.

This episode was published on Mar 5, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from JAMA Author Interviews: Covering research in medicine, science, & clinical practice. For physicians, researchers, & clinicians. when more episodes are available from the podcast feed.